Leishmaniases are known as a group of globally widespread parasitic diseases caused by different species of
Leishmania, which is capable of infecting a wide variety of mammals. Currently, 22 species of
Leishmania are pathogen for human, infection when exposed to the natural transmission cycle (
1,
2). Leishmaniases have been considered tropical afflictions that together constitute one of the entities on the World Health Organization/Tropical six Disease Research (WHO/TDR) list of most important diseases (
3,
4). The disease is endemic in 88 countries of 5 continents with a total of 350 -million people at risk and 12 million cases. Among the 88 endemic countries, 22 are in the New World and 66 in the Old World with an estimated incidence of 1-1.5 million cases of cutaneous leishmaniasis (CL) and 500, 000 cases of visceral leishmaniasis (VL) (
3).
Direct microscopic examinations of stained smears or tissue samples usually used for CL diagnosis, is rapid and easy to use for diagnosis of cutaneous leishmaniasis. But studies in endemic regions revealed that a considerable number of clinically diagnosed cannot be confirmed by microscopic examinations and that methods with more sensitivity and specificity should be implemented in CL diagnosis (
5). Polymerase chain reaction (PCR)-based methods have provided the capability of diagnosis and also identification of
Leishmania species. Different species may have the criteria for the treatment phase (
6). The main biological samples used for diagnosis and identification of CL species by PCR are dermal scrapings or biopsies (
7,
8).